RIDGE DIAGNOSTICS, INC. Patent applications |
Patent application number | Title | Published |
20140257708 | DIAGNOSING AND MONITORING DEPRESSION DISORDERS - Materials and methods related to developing a disease score for a depression disorder (e.g., unipolar depression or major depressive disorder) in a subject using a multi-parameter system to measure a plurality of parameters, and an algorithm to calculate the score. The materials and methods can be used to, for example, diagnose depression disorders, or determine a subject's predisposition to develop a depression disorder. The methods also can include using a multi-parameter hypermapping system and algorithms related thereto. | 09-11-2014 |
20140135224 | QUANTITATIVE DIAGNOSTIC METHODS USING MULTIPLE PARAMETERS - Materials and methods related to diagnosing a clinical condition in a subject, or determining the subject's predisposition to develop the clinical condition, using a multi-parameter system to measure a plurality of parameters and an algorithm to determine a disease score. | 05-15-2014 |
20140128273 | Metabolic Syndrome and HPA Axis Biomarkers for Major Depressive Disorder - Materials and methods for using combinations of metabolic syndrome and HPA axis biomarkers for monitoring major depressive disorder. | 05-08-2014 |
20110213219 | Multiple Biomarker Panels to Stratify Disease Severity and Monitor Treatment of Depression - Materials and Methods for stratifying disease severity and for monitoring major depressive disorder are provided. | 09-01-2011 |
20100280760 | BIOMARKERS FOR MONITORING TREATMENT OF NEUROPSYCHIATRIC DISEASES - Methods for identifying and measuring pharmacodynamic biomarkers of neuropsychiatric disease, and for monitoring a subject's response to treatment. For example, materials and methods for monitoring the effectiveness of transcranial magnetic stimulation in a subject having a neuropsychiatric disease are provided. | 11-04-2010 |
20100280562 | BIOMARKERS FOR MONITORING TREATMENT OF NEUROPSYCHIATRIC DISEASES - Methods for identifying and measuring pharmacodynamic biomarkers of neuropsychiatric disease, and for monitoring a subject's response to treatment. For example, materials and methods for monitoring the effectiveness of vagus nerve stimulation in a subject having a neuropsychiatric disease are provided. | 11-04-2010 |
20100100333 | HUMAN BIOMARKER HYPERMAPPING FOR DEPRESSIVE DISORDERS - Materials and Methods related to diagnosing depression disorders, or determining a subject's predisposition to develop a depression disorder, using a multi-parameter hypermapping system and algorithms related thereto. | 04-22-2010 |